Identifying tumor cell growth inhibitors by combinatorial chemistry and zebrafish assays.
Cyclin-dependent kinases (CDKs) play important roles in regulating cell cycle progression, and altered cell cycles resulting from over-expression or abnormal activation of CDKs observed in many human cancers. As a result, CDKs have become extensive studied targets for developing chemical inhibitors...
Main Authors: | Jing Xiang, Hongbo Yang, Chao Che, Haixia Zou, Hanshuo Yang, Yuquan Wei, Junmin Quan, Hui Zhang, Zhen Yang, Shuo Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2633036?pdf=render |
Similar Items
-
A novel anti-tumor inhibitor identified by virtual screen with PLK1 structure and zebrafish assay.
by: Jing Lu, et al.
Published: (2013-01-01) -
Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors.
by: Jinn-Moon Yang, et al.
Published: (2007-01-01) -
Exploration of dynamic combinatorial chemistry in enzyme-inhibitor discovery
by: Savovic, Jelena
Published: (2003) -
A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors.
by: Chengjian Zhao, et al.
Published: (2011-01-01) -
DEVELOPMENT AND OPTIMIZATION OF PROTEIN-PROTEIN INTERACTION INHIBITORS BY COMBINATORIAL AND MEDICINAL CHEMISTRY
by: Lian, Wenlong
Published: (2015)